GenoSafe
PrivateLast Round
Corporate Funding
Sep 2, 2003
Total Funding Raised
$710,000
Company Overview
GenoSafe operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Corporate Funding round in September 2003.
GenoSafe is a biotechnology company that provides contract research and consulting services for the evaluation of the quality, safety, and efficacy of innovative biological products, including gene and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Compliance, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoSafe Comparables
Compare GenoSafe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProtaGene | 88% | |
| Clean Biologics | 80% | |
| KCAS Bioanalytical and Biomarker Services | 78% |
For institutional investors. Book with your work email.
GenoSafe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 2, 2003 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 1372% MoM, from 53 to 780.
- Jan 1, 2026
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
GenoSafe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenoSafe's valuation, stock price, and market status.
Is GenoSafe a public or private company?
GenoSafe is a private company.
What is the current stock price of GenoSafe?
GenoSafe is a private company, so its shares have no public market price. Caplight tracks GenoSafe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenoSafe worth (valuation)?
Valuation information for GenoSafe is not publicly available.
Can I buy GenoSafe stock?
GenoSafe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenoSafe's last funding round?
GenoSafe's most recent funding round was Corporate Funding on September 2, 2003.
Who are the main investors in GenoSafe?
Investor information for GenoSafe is not publicly disclosed.
Will GenoSafe IPO soon?
No public IPO plans have been announced for GenoSafe.
How can I track GenoSafe secondary market activity?
Caplight tracks bids, offers, and trades in GenoSafe's shares on secondary markets.